ENDRA LIFE SCIENCES INC
NDRANASDAQTrading Snapshot
- Day Range
- $5.84 – $5.96
- 52-Week Range
- $2.96 – $9.85
- Volume
- $4.08B
- Avg Volume
- $3.88B
- Shares Outstanding
- 2.1M
- Next Earnings
- Oct 22, 2026
Fundamentals Snapshot
- Annual Revenue
- $373,867
- Last Q Revenue
- $93,282
- P/E Ratio
- —
- P/S Ratio
- 23.3x
- EPS (TTM)
- $-5.98
- Dividend Yield
- —
- Dilution (1yr)
- +46.6%
Why Investors Own NDRA
- ✓High-growth profile — revenue up +17.8% YoY with expanding US Equity exposure.
- ✓Healthy economics — 30% gross margin and 6% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
ENDRA LIFE SCIENCES INC
NDRA
StockOtter · stockotter.spaceAbout ENDRA LIFE SCIENCES INC
ENDRA Life Sciences Inc. specializes in advancing the capabilities of clinical diagnostic ultrasound. The company's primary development is thermo-acoustic enhanced ultrasound technology, which operates by emitting sound waves that echo off internal body components such as tissues, organs, and blood. This innovation is utilized in managing nonalcoholic fatty liver disease, meticulously monitoring temperature during thermoablative surgical procedures, detailed vascular imaging, and assessing tissue perfusion. Furthermore, ENDRA offers other diagnostic imaging modalities, including computed tomography (CT), magnetic resonance imaging (MRI), and conventional ultrasound. These instruments empower physicians to visualize internal anatomy, aiding in treatment guidance and the identification of various medical conditions like bone fractures, cancerous growths, indicators of heart disease, or internal bleeding. The company also maintains a research collaboration agreement with General Electric Company. Established in 2007, ENDRA Life Sciences Inc. is headquartered in Ann Arbor, Michigan.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
ENDRA Life Sciences (NASDAQ:NDRA) Shares Climb 1.9% – Time to Buy?
Shares of ENDRA Life Sciences Inc. (NASDAQ: NDRA - Get Free Report) were up 1.9% during trading on Friday. The company traded as high as $6.32 and last traded at $6.04. 37,386 shares were traded during mid-day trading, a
ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver
ASP Isotopes Issues Letter to Shareholders
DALLAS, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes”, “ASPI” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of c
Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company
DALLAS & ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASLD--ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or “ASPI”), an advanced materials company focused on developing technologies and processes for the production
Halper Sadeh LLC is Investigating Whether BOLD and NDRA are Obtaining Fair Deals for their Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.